[The therapeutic efficacy of a gonococcal vaccine].
The therapeutic efficacies of 2 gonococcal vaccines are compared. One of them is made from gonococcal strains selected for their antigenic characteristics, the other is a commercial vaccine prepared from a random sample of gonococcal strains. The studies have demonstrated a higher therapeutic efficacy of the former vaccine. This fact calls for the creation at production centers of permanent collections of antigenically full-value gonococcal cultures; such collections will help improve the gonococcal vaccine, standardize it, and enhance its biological activity.
Andreeva
Z M
ZM
Bednova
V N
VN
Shevchenko
N M
NM
Malyshev
A M
AM
Danilenko
T I
TI
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000942:Antigens, Bacterial / Q000276:immunology; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006069:Gonorrhea / Q000276:immunology / Q000628:therapy*; D006801:Humans; D008297:Male; D009344:Neisseria gonorrhoeae / Q000276:immunology*
D000900:Anti-Bacterial Agents; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines
Izuchenie terapevticheskoĭ éffektivnosti gonokokkovoĭ vaktsiny.